{"DataElement":{"publicId":"8146805","version":"1","preferredName":"Leukemia Immunophenotype Detection Method Type","preferredDefinition":"A description of leukemia immunophenotype detection method.","longName":"8146798v1.0:8146802v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"8146798","version":"1","preferredName":"Leukemia Immunophenotype Detection Method","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years._The characterization of a set of cells according to the antigens expressed._The activity of perceiving, discerning, discovering or identifying._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"8148270v1.0:2730351v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"8148270","version":"1","preferredName":"Leukemia Immunophenotype Detection","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:The characterization of a set of cells according to the antigens expressed.:The activity of perceiving, discerning, discovering or identifying.","longName":"C3161:C20072:C16210","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunophenotype","conceptCode":"C20072","definition":"The characterization of a set of cells according to the antigens expressed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC04EEFA-8D3E-1865-E053-4EBD850A7509","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"ONEDATA","dateModified":"2022-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2730351","version":"1","preferredName":"Method","preferredDefinition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4692C84F-EB01-324C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"ONEDATA","dateModified":"2008-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD4FAC-DD02-1ADB-E053-4EBD850A3ECA","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":"2022.10.3 Released per ticket request CADSR0001568. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8146802","version":"1","preferredName":"Leukemia Immunophenotype Detection Method Type","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years._The characterization of a set of cells according to the antigens expressed._The activity of perceiving, discerning, discovering or identifying._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Something distinguishable as an identifiable class based on common qualities.","longName":"8146802v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Original leukemia immunophenotype","valueDescription":"Original Leukemia Immunophenotype","ValueMeaning":{"publicId":"8146803","version":"1","preferredName":"Original Leukemia Immunophenotype","longName":"8146803","preferredDefinition":"Preceding all others in time or being as first made or performed.: A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.: The characterization of a set of cells according to the antigens expressed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Original","conceptCode":"C25604","definition":"Preceding all others in time or being as first made or performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunophenotype","conceptCode":"C20072","definition":"The characterization of a set of cells according to the antigens expressed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD4FAC-DD48-1ADB-E053-4EBD850A3ECA","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"ONEDATA","dateModified":"2022-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFD4FAC-DD61-1ADB-E053-4EBD850A3ECA","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"ONEDATA","dateModified":"2022-04-06","deletedIndicator":"No"},{"value":"Aberrant phenotype","valueDescription":"Abnormal Phenotype","ValueMeaning":{"publicId":"8146804","version":"1","preferredName":"Abnormal Phenotype","longName":"8146804","preferredDefinition":"The expression of traits associated with a disease or abnormality, or the loss of expression of traits associated with a normal or healthy phenotype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal Phenotype","conceptCode":"C186587","definition":"The expression of traits associated with a disease or abnormality, or the loss of expression of traits associated with a normal or healthy phenotype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD4FAC-DD6D-1ADB-E053-4EBD850A3ECA","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"ONEDATA","dateModified":"2022-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFD4FAC-DD86-1ADB-E053-4EBD850A3ECA","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"ONEDATA","dateModified":"2022-04-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8148269","version":"1","preferredName":"Leukemia Immunophenotype Detection Method Type","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:The characterization of a set of cells according to the antigens expressed.:The activity of perceiving, discerning, discovering or identifying.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:Something distinguishable as an identifiable class based on common qualities.","longName":"8148269v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Immunophenotype","conceptCode":"C20072","definition":"The characterization of a set of cells according to the antigens expressed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC04ACBD-8046-15C3-E053-4EBD850AEB0C","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"ONEDATA","dateModified":"2022-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD4FAC-DD2E-1ADB-E053-4EBD850A3ECA","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":"2022.10.3 Released per ticket request CADSR0001568. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TDIS_AML_immunopheno_detec_ty","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_ALL_immunopheno_detec_ty","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the leukemia immunop","type":"Preferred Question Text","description":"What was the leukemia immunophenotype detection method?","url":null,"context":"NHLBI"},{"name":"Which leukemia phenotype was used for detection?","type":"Application Standard Question Text","description":"Which leukemia phenotype was used for detection?","url":null,"context":"NHLBI"},{"name":"Which leukemia phenotype was used for detection?","type":"Alternate Question Text","description":"Which leukemia phenotype was used for detection?","url":null,"context":"NHLBI"},{"name":"NMDP Text 1","type":"Alternate Question Text","description":"Which leukemia immunophenotype was used for measurable residual disease detection?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBFD3144-9DE7-2296-E053-4EBD850ACBC7","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-06","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":"2022.10.3 Released per ticket request CADSR0001568. ak","unresolvedIssues":null,"deletedIndicator":"No"}}